Neuroblastoma, a devastating cancer affecting primarily children under five, stands as one of the most aggressive solid tumors in pediatric populations, with high-risk cases often showing dismal outcomes despite rigorous treatments. With only about half of these young patients achieving a cure
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research and development, coupled with a keen understanding of tech and innovation, has positioned him at the forefront of groundbreaking advancements in cancer treatment. Today, we’re diving into
The biotechnology sector often rides a rollercoaster of high hopes and sharp setbacks, and few cases illustrate this better than the recent plunge in Exelixis’ stock value following the release of data from its STELLAR-303 trial. Focused on zanzalintinib, an experimental drug for metastatic
As we dive into the complex world of healthcare policy, I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose deep understanding of technology and innovation in the industry, coupled with extensive experience in research and development, offers invaluable insights. Today,
In the heart of Wirral, UK, a cherished annual tradition is gearing up to bring holiday cheer and hope to countless lives through the Wirral Bazaar, hosted by North West Cancer Research at Hulme Hall in Port Sunlight on November 3 and 4. This festive event, steeped in over three decades of history,
The startling reality that over 30% of adults may carry dangerous fat deposits deep within their abdomen or liver, even without visible signs of obesity, has sparked intense discussion in the medical community. This hidden fat, often undetectable through traditional measures like body mass index
